283例药物热报告分析

doi:10.19803/j.1672-8629.2022.03.22

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (3): 328-332.
DOI: 10.19803/j.1672-8629.2022.03.22

283例药物热报告分析

刘娟, 张晶^*, 杨艳玲, 王银辉

恩施州土家族苗族自治州中心医院临床药学科,湖北恩施 445000

收稿日期:2020-04-22 出版日期:2022-03-15 发布日期:2022-03-16
通讯作者: ^*张晶,女,本科,副主任药师,临床药学。E-mail：448179354@qq.com
作者简介:刘娟,女,硕士,主管药师,临床药学。

Analysis of 283 cases of drug fever

LIU Juan, ZHANG Jing^*, YANG Yanling, WANG Yinhui

Department of Clinical Pharmacy, the Central Hospital of Enshi Tujia & Miao Autonomous Prefecture, Enshi Hubei 445000, China

Received:2020-04-22 Online:2022-03-15 Published:2022-03-16

摘要/Abstract

摘要： 目的探讨药物热的临床特点,为判断和治疗药物热提供参考。方法回顾性收集恩施州各医疗卫生单位2015年1月1日至 2019年12月31日上报国家药品不良反应监测系统发生药物热相关性报告,对筛选出的283例报告进行用药情况与临床表现汇总分析。结果致热药物主要是中药制剂78例（27.56%）和抗菌药物64例（22.61%）。主要给药途径是静脉滴注,共249例（87.99%）。大部分药物热伴发其他症状,其中伴寒战、畏寒199例（42.98%）,伴皮损40例（8.64%）。85.87%的药物热出现在用药7 d内,但最晚可于用药后28 d出现。269例（94.70%）停药后当天体温缓解。结论我州中药制剂和抗菌药为主要致热药物,药物热常伴寒战,但仅少数伴发皮损等过敏症状。

关键词: 药物热, 药品不良反应, 发热

Abstract: Objective To explore the characteristics of drug fever and provide reference for related diagnosis and treatment. Methods Cases of drug fever reported by health institutions in Enshi Prefecture from January 1, 2015 to December 31, 2019 to the national adverse drug reaction detection system were retrospectively collected. A total of 283 cases were screened and analyzed. Results Seventy-nine of these cases (27.92%) were caused by traditional Chinese medicine, and 64 (22.61%) by antibiotics. The main route of administration was intravenous injection(249 cases, 87.99%). Most of these cases were accompanied by other symptoms, 199 of which were chills (46.28%) and 40 were skin damage (9.30%). Drug fever in most (85.87%) of the cases occurred within 7 days of administration, but it could occur as late as 28 days after administration. 268 of these cases (94.70%) had temperature remission soon after drug withdrawal. Conclusion Traditional Chinese medicine and antibiotics are the drugs mainly responsible for drug fever in Enshi prefecture. Patients with drug fever often have chills, and only a few have such allergic symptoms as skin lesions.

Key words: drug fever, adverse drug reaction, fever

中图分类号:

R969

刘娟, 张晶, 杨艳玲, 王银辉. 283例药物热报告分析[J]. 中国药物警戒, 2022, 19(3): 328-332.

LIU Juan, ZHANG Jing, YANG Yanling, WANG Yinhui. Analysis of 283 cases of drug fever[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 328-332.

参考文献

[1] RUCHI AP, JASON CG.Drug fever[J]. Pharmacotherapy,2010,30(1): 57-69.
[2] JI WJ, YAN XB.Clinical characteristics of 1838 patients with fever of unknown origin[J]. Inter J Epidemiol Infect Dis(国际流行病学传染病学杂志), 2019, 46(3): 185-189.
[3] BENJAMIN AL, JAN VH.Drug fever[J]. JAMA, 1981, 245(8): 851-854.
[4] SU CH, WANG X.Introduction of drug fever[J]. China Pharmacist(中国药师), 2011, 14(3): 422-424.
[5] CHEN XQ, JIN YY, TANG G. New Pharmacology(新编药物学)[M]. 17 th Ed. Beijing: People's Medical Publishing House, 2010: 11-14.
[6] Department of Drug Safety Supervidion, China Food and Drug Administration;National Center for ADR Monitoring, China.Handbook of adverse drug reaction reporting and monitoring[EB/OL].(2012-11)[2020-03-10]. https://www.cdr-adr.org.cn/drug_1/zcfg_1/zcfg_zdyz/202009/t20200924_47831. html.
[7] LIU B, ZHOU XZ, WANG CY, et al.Domestic literature analysis of 422 cases on drug fever[J]. China Pharm(中国药业), 2016, 25(21): 74-78.
[8] FANG Y, XIAO HP, TANG SJ, et al.Clinical characteristics and treatment measures of drug fever caused by anti-tuberculosis drugs[J]. Chin J Clinicians(中华临床医师杂志), 2010, 4(11): 2237-2240.
[9] DOMINIQUE V, CHRISTINE L, BRUNO M.Drug Fever a descriptive cohort study from the French national pharmacovigilance database[J]. Drug Saf, 2012, 35(9): 759-767.
[10] ZHOU D.Clinical diagnosis and treatment of antibiotic-associated drug fever[J]. Herald of Medicine(医药导报), 2015, 1(34): 50-52.
[11] YIN J, JIN SH.Discussion on adverse drug reactions of the traditional chinese medicine injections and risk control measures[J]. Chinese Pharmaceutical Affairs(中国药事), 2013, 27(9): 989-993.
[12] XU N, HU YJ, HUANG XP.Clinical analysis of drug fever caused by common antibiotics[J]. Chin J Prim Med Pharm(中国基层医药), 2011, 18(15): 2083-2084.
[13] GUO S, LI R.Analysis of 78 cases of drug fever in children[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2016, 13(7): 426-428.
[14] WANG CR.A retrospective analysis of drug fever caused by piperacillin sodium and tazobactam sodium for injection[J]. Chin Hosp Pharm J(中国医院药学杂志), 2019, 39(22): 2334-2337.
[15] ZHU H.A case of drug fever caused by β-lactam antibiotics[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2011, 8(11): 103.
[16] WANG JZ, QIAN RZ.Pathophysiology(病理生理学)[M]. 9th ed. Beijing: People's Medical Publishing House, 2018.
[17] ZHAO Y, KANG HJ, WANG B, et al.Diagnostic thinking of drug fever: a report of two cases[J]. Clinical Misdiagnosis & Mistherapy(临床误诊误治), 2014, 27(1): 64-67.

283例药物热报告分析

Analysis of 283 cases of drug fever

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[9]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[10]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[11]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[12]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[13]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[14]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.
[15]	刘文东, 崔欢欢, 王晓晗, 苏娴, 王海学. 我国儿童用药临床试验期间药物警戒监管体系现状及思考[J]. 中国药物警戒, 2023, 20(9): 1002-1006.